|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current Assets: | ||||||||
| Cash | ||||||||
| Accounts receivable | ||||||||
| Prepaid contracts | ||||||||
| Prepaid and Other current assets | ||||||||
| Inventory, net | ||||||||
| Other current assets | ||||||||
| Total current assets | ||||||||
| Operating lease right of use asset, net | ||||||||
| Prepaid contracts, noncurrent | ||||||||
| Other assets | ||||||||
| Total assets | ||||||||
| Liabilities and Stockholders’ Deficit | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Accrued compensation | ||||||||
| Accrued interest | ||||||||
| Other current liability | ||||||||
| Deferred revenue | ||||||||
| Operating lease liability | ||||||||
| Note payable, related party | ||||||||
| Nonrelated Party | ||||||||
| Related Party | ||||||||
| Derivative liability | ||||||||
| Convertible notes payable, fair value | ||||||||
| Refund liability | ||||||||
| Total current liabilities | ||||||||
| Convertible notes payable, net of discount of $0 and $43,288 | ||||||||
| Operating lease liability, net of current portion | ||||||||
| Total liabilities | ||||||||
| Stockholders’ Deficit: | ||||||||
| Common stock, par value $0.0001; 500,000,000 and 125,000,000 shares authorized, respectively; 664,670 and 459,286 issued and outstanding, respectively | ||||||||
| Additional paid in capital | ||||||||
| Receivables for sale of common stock | ||||||||
| Accumulated deficit | ||||||||
| Total stockholders’ deficit | ||||||||
| Total liabilities and stockholders’ deficit |
Loading...
